BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 17234259)

  • 1. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.
    Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X
    Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reversing paclitaxel-resistance of SKOV3-TR30 cell line by curcumin].
    Qiu J; Fu YF; Cheng Q; Cheng XD; Xie X; Lü WG
    Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(27):1926-8. PubMed ID: 23134969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells.
    Ling YH; Yang Y; Tornos C; Singh B; Perez-Soler R
    Cancer Res; 1998 Aug; 58(16):3633-40. PubMed ID: 9721872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension.
    Lens SM; Wolthuis RM; Klompmaker R; Kauw J; Agami R; Brummelkamp T; Kops G; Medema RH
    EMBO J; 2003 Jun; 22(12):2934-47. PubMed ID: 12805209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p55CDC/hCDC20 is associated with BUBR1 and may be a downstream target of the spindle checkpoint kinase.
    Wu H; Lan Z; Li W; Wu S; Weinstein J; Sakamoto KM; Dai W
    Oncogene; 2000 Sep; 19(40):4557-62. PubMed ID: 11030144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spindle checkpoint function requires Mad2-dependent Cdc20 binding to the Mad3 homology domain of BubR1.
    Davenport J; Harris LD; Goorha R
    Exp Cell Res; 2006 Jun; 312(10):1831-42. PubMed ID: 16600213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
    Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BubR1 is required for a sustained mitotic spindle checkpoint arrest in human cancer cells treated with tubulin-targeting pyrrolo-1,5-benzoxazepines.
    Greene LM; Campiani G; Lawler M; Williams DC; Zisterer DM
    Mol Pharmacol; 2008 Feb; 73(2):419-30. PubMed ID: 17991869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of glycogen synthase kinase-3 in ovarian carcinoma cells with acquired paclitaxel resistance.
    Fu Y; Hu D; Qiu J; Xie X; Ye F; Lu WG
    Int J Gynecol Cancer; 2011 Apr; 21(3):439-44. PubMed ID: 21436692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint.
    Kim HS; Park KH; Kim SA; Wen J; Park SW; Park B; Gham CW; Hyung WJ; Noh SH; Kim HK; Song SY
    Mutat Res; 2005 Oct; 578(1-2):187-201. PubMed ID: 16112690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Mad2 on paclitaxel-induced cell death in ovarian cancer cells.
    Hao X; Zhou Z; Ye S; Zhou T; Lu Y; Ma D; Wang S
    J Huazhong Univ Sci Technolog Med Sci; 2010 Oct; 30(5):620-5. PubMed ID: 21063845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol.
    Kienitz A; Vogel C; Morales I; Müller R; Bastians H
    Oncogene; 2005 Jun; 24(26):4301-10. PubMed ID: 15782113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of a functional spindle checkpoint for arsenite-induced apoptosis.
    Wu YC; Yen WY; Yih LH
    J Cell Biochem; 2008 Oct; 105(3):678-87. PubMed ID: 18668508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of S100P associated with paclitaxel resistance in ovarian cancer cell line.
    Gao JH; He ZJ; Wang Q; Li X; Li YX; Liu M; Zheng JH; Tang H
    Chin Med J (Engl); 2008 Aug; 121(16):1563-8. PubMed ID: 18982869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells.
    Cheung HW; Jin DY; Ling MT; Wong YC; Wang Q; Tsao SW; Wang X
    Cancer Res; 2005 Feb; 65(4):1450-8. PubMed ID: 15735033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.
    Gupta A; Inaba S; Wong OK; Fang G; Liu J
    Oncogene; 2003 Oct; 22(48):7593-9. PubMed ID: 14576821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint.
    Sudo T; Nitta M; Saya H; Ueno NT
    Cancer Res; 2004 Apr; 64(7):2502-8. PubMed ID: 15059905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A; Soprano DR; Parekh HK
    Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
    Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
    Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.